
Loading, please wait...

Loading, please wait...

Managing drug-resistant epilepsy (DRE) in pediatric oncology survivors remains a significant clinical challenge. Recently, surgeons utilized hemispherotomy for ATRT epilepsy to address frequent seizures in a 6-year-old boy. This patient previously underwent treatment for a large left thalamic atypical teratoid rhabdoid tumor (ATRT). Consequently, he developed refractory tonic seizures that significantly impaired his quality of life.
The patient's initial treatment included subtotal resection, chemotherapy, and radiation. However, two years later, he experienced frequent seizures despite multiple antiseizure medications. Clinical evaluation revealed seizure onset in the left hemisphere along with hypometabolism. Because the child already had right-sided hemiparesis and hemifield neglect, the surgical team prioritized seizure control. Therefore, they performed a left peri-insular hemispherotomy.
Following the surgery, the patient remained seizure-free without any worsening of his neurological function. This case illustrates that aggressive surgical interventions can benefit patients with unilateral disease and preexisting deficits. Furthermore, early surgical evaluation is vital when medication fails to control epilepsy in brain tumor survivors. Clinicians should always weigh surgical risks against the patient's functional baseline to achieve the best outcomes.
While data on ATRT specifically is rare, hemispherotomy generally provides excellent seizure control in children with unilateral hemispheric pathology. Many patients achieve complete seizure freedom even after high-grade tumor treatment.
If a child already has a dense motor deficit or hemianopia from a previous tumor or surgery, a hemispherotomy often does not significantly worsen their functional baseline. The goal is to trade a non-functional hemisphere for improved seizure control.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a patient-physician relationship. Refer to the latest local and national guidelines for clinical practice.
References
Hect JL et al. Hemispherotomy for atypical teratoid rhabdoid tumor-associated drug-resistant epilepsy: illustrative case. J Neurosurg Case Lessons. 2026 Apr 13. doi: undefined. PMID: 41974062.
Lersch R et al. Seizure outcomes following epilepsy surgery in pediatric and young adult patients with high-grade brain tumors: Results from a European survey. Epilepsia. 2025 Mar 01. doi: 10.1111/epi.18065.
National Institute of Neurological Disorders and Stroke. Epilepsy Information Page. Available at: https://www.ninds.nih.gov/health-information/disorders/epilepsy.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This case report details a 6-year-old boy undergoing a hemispherotomy for drug-resistant epilepsy following ATRT treatment, resulting in seizure freedom....
6 months ago

Following Nigeria's first recorded Ebola case linked to regional travel, the Africa CDC has convened an emergency ministerial summit. This alert underscores critical clinical priorities for healthcare professionals, including differentiating early viral infection from malaria, implementing barrier nursing, and triage.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today